ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,268Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 680

$1.44M Total Retail Price of All Prescriptions

Rank: 24 out of 680

721 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 721 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 721 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 21,436 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 884 742 1 5
AMLODIPINE BESYLATE 723 698 2 1
FUROSEMIDE 687 600 3 6
SIMVASTATIN 675 577 4 3
OMEPRAZOLE 662 576 5 7
LEVOTHYROXINE SODIUM 624 548 6 2
DONEPEZIL HCL 433 420 7 27
HYDROCODONE-ACETAMINOPHEN 431 357 S3 8 4
POTASSIUM CHLORIDE 404 344 9 14
METOPROLOL TARTRATE 395 316 10 12
POLYETHYLENE GLYCOL 3350 391 321 11 62
TRAMADOL HCL 356 325 12 18
SERTRALINE HCL 333 304 13 28
METFORMIN HCL 332 302 14 8
HYDROCHLOROTHIAZIDE 327 299 15 9
NOVOLIN R 320 225 16 113
NAMENDA 306 302 17 35
LANTUS 292 180 18 49
MEGESTROL ACETATE 290 280 R 19 88
ATENOLOL 275 273 20 19
CLONIDINE HCL 258 229 21 36
GABAPENTIN 253 199 22 15
RISPERIDONE 253 229 22 80
KLOR-CON M20 243 217 24 61
PANTOPRAZOLE SODIUM 231 199 25 30
OXYBUTYNIN CHLORIDE ER 225 191 26 143
METOPROLOL SUCCINATE 221 186 27 13
ESCITALOPRAM OXALATE 215 153 28 45
WARFARIN SODIUM 195 190 29 20
PRAVASTATIN SODIUM 193 140 30 10
TAMSULOSIN HCL 189 149 31 34
CYMBALTA 186 163 32 46
CLOPIDOGREL 184 169 33 26
LACTULOSE 181 122 34 92
IPRATROPIUM-ALBUTEROL 178 162 35 207
NEXIUM 177 135 36 16
CITALOPRAM HBR 174 128 37 22
HYDRALAZINE HCL 168 131 38 71
DIOVAN 166 160 39 31
DIGOXIN 162 156 40 58
NIFEDIPINE ER 160 137 41 75
SANTYL 157 132 42 170
ATORVASTATIN CALCIUM 154 132 43 11
TRAZODONE HCL 153 101 44 48
CARVEDILOL 152 119 45 23
CIPROFLOXACIN HCL 149 140 46 57
CEPHALEXIN 142 125 47 149
QUETIAPINE FUMARATE 139 135 48 64
MELOXICAM 134 124 49 24
AZITHROMYCIN 133 111 50 42
AMITRIPTYLINE HCL 133 117 R 50 47
BACLOFEN 133 92 50 140
ALLOPURINOL 132 119 53 33
HUMULIN R 129 110 54 195
ZOLPIDEM TARTRATE 125 120 55 17
METFORMIN HCL ER 125 115 55 54
PLAVIX 125 115 55 39
DIVALPROEX SODIUM 122 97 58 110
PHENYTOIN SODIUM EXTENDED 121 55 59 115
FLUOXETINE HCL 114 89 60 74
SULFAMETHOXAZOLE-TRIMETHOPRIM 113 100 61 94
FAMOTIDINE 113 97 61 89
CRESTOR 111 101 63 25
LATANOPROST 110 110 64 209
CARBIDOPA-LEVODOPA 106 87 65 117
LEVETIRACETAM 101 33 66 120
ISOSORBIDE MONONITRATE ER 100 98 67 59
LOSARTAN POTASSIUM 100 98 67 21
TRIAMCINOLONE ACETONIDE 98 93 69 199
ALENDRONATE SODIUM 97 85 70 32
AMIODARONE HCL 97 84 70 158
BUMETANIDE 96 50 72 102
PROMETHAZINE HCL 95 51 R 73 96
PREDNISONE 94 89 74 50
AMLODIPINE BESYLATE-BENAZEPRIL 88 88 75 43
ALBUTEROL SULFATE 87 86 76 154
NOVOLIN N 86 85 77 225
OLANZAPINE 86 48 77 116
JANTOVEN 85 85 79 147
DILTIAZEM 24HR ER 85 72 79 132
TAMIFLU 85 77 79 316
TRIAMTERENE-HCTZ 85 85 79 52
SPIRIVA 84 83 83 70
HUMALOG 84 55 83 196
LYRICA 83 44 85 77
RANITIDINE HCL 82 74 86 56
PHENYTOIN 81 60 87 354
DIVALPROEX SODIUM ER 80 66 88 148
DOXAZOSIN MESYLATE 80 80 88 73
AGGRENOX 76 76 90 177
TRAMADOL HCL-ACETAMINOPHEN 76 68 90 153
CYCLOBENZAPRINE HCL 75 46 R 92 81
SPIRONOLACTONE 74 30 93 82
FLUTICASONE PROPIONATE 72 47 94 41
AMOXICILLIN 70 57 95 111
IPRATROPIUM BROMIDE 70 66 95 211
GLYBURIDE MICRONIZED 69 59 R 97 232
NOVOLOG 69 49 97 167
LEXAPRO 68 50 99 128
SPS 68 47 99 340
ADVAIR DISKUS 68 65 99 53
CEFTRIAXONE 65 52 102 347
PAROXETINE HCL 65 64 102 76
MIRTAZAPINE 64 56 104 78
FINASTERIDE 63 49 105 109
ABILIFY 62 24 106 178
LIPITOR 61 58 107 68
SEROQUEL 61 56 107 123
ENOXAPARIN SODIUM 60 51 109 260
DILTIAZEM 24HR CD 59 59 110 182
NITROFURANTOIN MONO-MACRO 59 59 110 172
CARAFATE 58 32 112 273
CELEBREX 58 38 112 90
DOXYCYCLINE HYCLATE 56 44 114 95
NYSTATIN 55 52 115 191
HYDROXYZINE HCL 55 29 R 115 267
NOVOLIN 70-30 54 15 117 236
GLIPIZIDE 54 49 117 63
METOCLOPRAMIDE HCL 54 24 117 118
MECLIZINE HCL 53 50 120 103
LEVEMIR 53 53 120 248
EXELON 52 52 122 112
BENICAR 51 51 123 131
AVODART 51 44 123 218
RAMIPRIL 51 51 123 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 5, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.